Financial Results
Q1 2026 – coming soon!
Fresenius will publish its Q1 2026 results on May 6, 2026. The conference call will take place at 1:30 pm (CEST). The dial-in details will follow soon.
As a service to investors and sell-side analysts, we provide an Aide Memoire ahead of its quiet period starting April 23, 2026. This document includes a summary of relevant information that Fresenius has communicated previously or made publicly available to the capital market or otherwise. The Aide Memoire may prove helpful in assessing Fresenius’ financial performance ahead of the publication of its Q1/26 financial results on May 6, 2026.
Q4/25 Results
WebcastDocuments
Q1/26 Aide Memoire (PDF)Selected Key Figures FY/2025
GROUP REVENUE 1
€ 22554 m
+ 7% 2
FY/24: €21,526 m
GROUP EBIT 1
€ 2595 m
+6% 3
FY/24: €2,489 m
NET INCOME 1, 4
€ 1619 m
+12% 3
FY/24: €1,461 m
EPS 1, 4
€ 2.87
+12% 3
FY/24: €2.59
1 Before special items
2 Organic growth rate adjusted for accounting effects related to Argentina hyperinflation
3 Growth rate at constant currency (cc) and adjusted for Argentina hyperinflation
4 Excluding Fresenius Medical Care
Revenue by business segment
| € in millions | FY/25 | FY/24 | Growth at actual rates | Growth at constant rates1 | Organic growth2 | Acquisitions/Divestitures | % of total revenue |
|---|---|---|---|---|---|---|---|
Fresenius Kabi | 8,612 | 8,414 | 2% | 6%1 | 7%2 | -1% | 38% |
Fresenius Helios | 13,550 | 12,739 | 6% | 7% | 7% | 0% | 60% |
Total | 22,554 | 21,526 | 5% | 6% | 7% | -1% | 100%3 |
-
1 Growth rate adjusted for Argentina hyperinflation
2 Organic growth rate adjusted for accounting effects related to Argentina hyperinflation
3 Remaining 2% Corporate/Other revenue
Before special items